SCHEMBL19638102

SCHEMBL19638102

CC(C)(C)OC(OC(C)(C)C)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.42
CHRNB2 P17787 1/20 0.41
CHRNA4 P43681 1/20 0.41
CYP17A1 P05093 2/20 0.39
ACP3 P15309 2/20 0.38
ALDH1A1 P00352 2/20 0.38
KIF11 P52732 1/20 0.35
CYP1A2 P05177 1/20 0.35
GAA P10253 1/20 0.35
CYP2C9 P11712 1/20 0.35
PKM P14618 1/20 0.35
CYP2C19 P33261 1/20 0.35
PDCD1 Q15116 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4004807 0.87 RIPK1 (0.39) GAASLC6A4SLC6A3MAPK1
SCHEMBL28316488 0.77 KMT2A (0.36) ALDH1A1SLC6A4SLC6A3MAPK1
SCHEMBL2522160 0.76 PTGS2 (0.47) PTGS2CHRNB2CHRNA4ACP3ALDH1A1
SCHEMBL18297904 0.75 RIPK1 (0.34) GAASLC6A4SLC6A3MAPK1
SCHEMBL28346241 0.72 PTGS2 (0.48) PTGS2CHRNB2CHRNA4CYP17A1ACP3
Biphenyl SCHEMBL21467263 0.72 ALDH1A1 (0.50) ALDH1A1KIF11CYP1A2CYP3A4SLC6A4
SCHEMBL22311218 0.71 PTGS2 (0.46) PTGS2CHRNB2CHRNA4CYP17A1ALDH1A1
SCHEMBL26826452 0.70 PTGS2 (0.50) PTGS2CHRNB2CHRNA4CYP17A1ACP3
SCHEMBL28346107 0.69 CHRNB2 (0.44) PTGS2CHRNB2CHRNA4CYP17A1ACP3
Biphenyl SCHEMBL1193167 0.69 ALDH1A1 (0.53) ALDH1A1KIF11CYP1A2CYP3A4SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117500864-A Curable resin composition, prepreg, and cured product thereof 日本化药株式会社 2024-02-02 CN disclosed
WO-2023063122-A1 CURABLE RESIN COMPOSITION, PREPREG, AND CURED PRODUCT OF SAME 日本化薬株式会社 2023-04-20 WO disclosed
CN-108884302-B Thermosetting resin composition, prepreg, and cured product thereof 日本化药株式会社 2023-03-28 CN disclosed
CN-108884212-B Maleimide resin, curable resin composition and cured product thereof 日本化药株式会社 2020-12-29 CN disclosed
US-20170369636-A1 Aromatic Amine Resin, Epoxy Resin Composition And Cured Product Thereof NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2017-12-28 US disclosed
EP-3248996-A1 AROMATIC AMINE RESIN, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF Nippon Kayaku Kabushiki Kaisha (JP) 2017-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170369636-A1 Aromatic Amine Resin, Epoxy Resin Composition And Cured Product Thereof H1-5, ASH2L, ASH1L PTGS2 3445/4885CHRNB2 814/4885CHRNA4 276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.